Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Pharmacogenet Genomics. 2013 Aug;23(8):383-94. doi: 10.1097/FPC.0b013e32833d7b45.

Genome-wide association studies in pharmacogenomics: successes and lessons.

Author information

  • 1Department of Statistics, Bioinformatics Research Center, North Carolina State University, Raleigh, North Carolina 27695-7566, USA. motsinger@stat.ncsu.edu

Abstract

OBJECTIVE:

As genotyping technology has progressed, genome-wide association studies (GWAS) have matured into efficient and effective tools for mapping genes underlying human phenotypes.

METHODS:

Recent studies have shown the utility of the GWAS approach for examining pharmacogenomic traits, including drug metabolism, efficacy, and toxicity.

RESULTS:

Application of GWAS to pharmacogenomic outcomes presents unique challenges and opportunities.

CONCLUSION:

In the current review, we discuss the potential promises and potential caveats of this approach specifically as it relates to pharmacogenomic studies. Concerns with study design, power and sample size, and analysis are reviewed. We further examine the features of successful pharmacogenomic GWAS, and describe consortia efforts that are likely to expand the reach of pharmacogenomic GWAS in the future.

PMID:
20639796
[PubMed - indexed for MEDLINE]
PMCID:
PMC3003940
[Available on 2014/8/1]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Lippincott Williams & Wilkins
    Loading ...
    Write to the Help Desk